US2018289312A1PendingUtilityA1

Mobile medical workstation

Assignee: WELCH ALLYN INCPriority: Aug 13, 2004Filed: Jun 8, 2018Published: Oct 11, 2018
Est. expiryAug 13, 2024(expired)· nominal 20-yr term from priority
A61B 5/0002A61B 5/7435A61B 50/13A61B 50/10A61B 5/412A61B 5/0402A61B 5/742A61B 5/1455A61B 5/743A61B 5/7475A61B 90/50A61B 2560/0437A61B 5/02A61B 5/14532A61B 5/1172A61B 2560/0456A61B 5/318
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A medical workstation is defined by a supporting structure having at least one medical diagnostic instrument disposed thereupon. A first display is further disposed on a first side of the supporting structure and a second display is disposed on a second side of the supporting structure in a manner substantially opposite from the first display. Each of the first and second displays are interconnected to the at least one medical diagnostic instrument to permit at least one of the displays in order to display diagnostic results and are tandemly or independently controllable.

Claims

exact text as granted — not AI-modified
1 . A method for determining the onset of sepsis in a patient, the method comprising:
 measuring at least two physiological parameters of a patient from the group including at least blood pressure, glucose, core body temperature, pulse rate, respiration rate and oxygen blood saturation; and   detecting changes in a patient condition based on changes in the two or more of the measured physiological parameters; and   predicting the onset of sepsis based on the changes of the two or more measured physiological parameters.   
     
     
         2 . The method according to  claim 1 , further comprising calculating a glycemic control score of a patient based on historical data and determining whether a patient's blood sugar level is within a predetermined range. 
     
     
         3 . The method according to  claim 2 , further comprising making a parallel determination as to whether the patient has had an infection. 
     
     
         4 . The method according to  claim 3 , further comprising identifying whether the patient has at least two signs of Systemic Inflammatory Response Syndrome (SIRS) if the existence of a known or suspected infection has been determined. 
     
     
         5 . The method according to  claim 4 , wherein identifying whether the patient has at least two signs of SIRS includes determining whether there are measured deviations in at least two of pulse rate, core body temperature, respiratory rate and white blood cell count of the patient. 
     
     
         6 . The method according to  claim 5 , wherein identifying whether the patient has at least two signs of SIRS further includes determining whether the patient includes at least 10 percent immature neutrophils. 
     
     
         7 . The method according to  claim 4 , further including the step of determining whether at least one organ of the patient is failing or dysfunctional if at least two signs of SIRS have been identified. 
     
     
         8 . The method according to  claim 1 , further including the step of determining a first control score based on a first physiological parameter and determining a second alert score based on at least a second and third physiological parameter. 
     
     
         9 . The method according to  claim 8 , wherein the first control score is based on the patient's blood sugar level. 
     
     
         10 . The method according to  claim 7 , further including using the first control score to determine the second alert score. 
     
     
         11 . A method for detecting the onset of sepsis of a patient, comprising:
 measuring physiological parameters from a patient including blood pressure, glucose, body temperature, pulse rate and blood oxygen saturation;   detecting changes in a patient condition based on changes in two or more measured physiological parameters of said patient; and   using the measured physiological parameters in a combined manner to predict the onset of sepsis.   
     
     
         12 . The method according to  claim 11 , including alerting a user if the changes in at least one measured physiological parameter exceeds a predetermined threshold. 
     
     
         13 . The method according to  claim 11 , including calculating a glycemic control score of a patient based on historical data and determining whether a patient's blood sugar level is within a predetermined range. 
     
     
         14 . The method according to  claim 13 , including making a parallel determination as to whether the patient has had an infection. 
     
     
         15 . The method according to  claim 14 , including identifying whether the patient has at least two signs of Systemic Inflammatory Response Syndrome (SIRS) if the existence of a known or suspected infection has been determined. 
     
     
         16 . The method according to  claim 15 , wherein identifying whether the patient has at least two signs of SIRS includes determining measured deviations in at least two of pulse rate, core body temperature, respiratory rate and white blood cell count of the patient. 
     
     
         17 . The method according to  claim 16 , including determining whether at least one organ of the patient is failing or dysfunctional if at least two signs of SIRS have been identified. 
     
     
         18 . The method according to  claim 11 , including determining a first control score based on a first physiological parameter and determining a second alert score based on at least a second and third physiological parameter. 
     
     
         19 . The method according to  claim 18 , wherein the first control score is based on the patient's blood sugar level. 
     
     
         20 . The method according to  claim 19 , including using the first control score to determine the second alert score.

Join the waitlist — get patent alerts

Track US2018289312A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.